Skip to main content
. 2021 Jun 22;13(5):1212–1222. doi: 10.1177/21925682211022315

Table 3.

30-day, 90-Day, 180-Day Complication Rates, Length of Stay, and Readmission Rates.

30-days Control
(n=125,527)
Alcohol use
(n=657)
Tobacco/nicotine use
(n=20,531)
Malnutrition
(n=3,183)
Dyslipidemia
(n=33,121)
Primary hypertension
(n=85,103)
Complications, n (%)
Myocardial infarction 475, 0.39% 0, 0% 111, 0.54% 210, 0.79% 337, 1.02% 403, 0.47%
Acute renal failure  564, 0.45% 3, 0.46% 49, 0.24% 25, 0.85% 381, 1.15% 651, 0.76%
Thromboembolic events 386, 0.31% 3, 0.46% 38, 0.19% 4, 0.13% 113, 0.34% 278, 0.33%
Death 78, 0.06% 1, 0.15% 14, 0.07% 2, 0.06% 34, 0.10% 54, 0.06%
Infection 1691, 1.35% 11, 1.67% 315, 1.53% 71, 2.20% 562, 1.70% 1572, 1.85%
Wound disruption 594, 0.47% 5, 0.76% 83, 0.40% 32, 1.00% 189, 0.57% 508, 0.60%
Neurological injury 199, 0.16% 0, 0% 42, 0.20% 10, 0.31% 50, 0.15% 115, 0.14%
Hardware failure 447, 0.36% 1, 0.15% 51, 0.25% 7, 0.22% 114, 0.34% 307, 0.36%
Hematoma formation 280, 0.22% 5, 0.76% 52, 0.25% 6, 0.19% 66, 0.20% 253, 0.30%
90-days Control
(n=100,650)
Alcohol Use
(n=496)
Tobacco/Nicotine Use
(n=16,580)
Malnutrition
(n=2,557)
Dyslipidemia
(n=25,674)
Primary Hypertension
(n=69,246)
Complications, n (%)
Myocardial infarction 710, 0.71% 0, 0% 133, 0.8% 33, 1.29% 442, 1.72% 624, 0.9%
Acute renal failure 688, 0.68% 12, 2.42% 95, 0.57% 36, 1.41% 463, 1.8% 827, 1.19%
Thromboembolic events  391, 0.39% 3, 0.6% 65, 0.39% 15, 0.59% 113, 0.44% 355, 0.51%
Death 110, 0.11% 8, 1.61% 11, 0.066% 11, 0.43% 41, 0.16% 85, 0.12%
Wound disruption 718, 0.71% 6, 1.21% 112, 0.68% 43, 1.68% 237, 0.92% 624, 0.9%
Neurological injury 192, 0.19% 0, 0% 41, 0.25% 6, 0.23% 58, 0.23% 125, 0.18%
Hardware failure 668, 0.66% 6, 1.21% 125, 0.75% 16, 0.63% 201, 0.78% 510, 0.74%
Hematoma formation 324, 0.32% 3, 0.6% 64, 0.38% 7, 0.27% 76, 0.3% 294, 0.43%
180-days Control
(n=66,980)
Alcohol Use
(n=310)
Tobacco/Nicotine Use
(n=11,312)
Malnutrition
(n=1,689)
Dyslipidemia
(n=16,971)
Primary Hypertension
(n=46,425)
Complications, n (%)
Myocardial infarction 618, 0.92% 0, 0% 129, 1.14% 24, 1.41% 436, 2.57% 633, 1.36%
Acute renal failure 641, 0.96% 6, 1.84% 99, 0.88% 28, 1.68% 402, 2.37% 703, 1.51%
Thromboembolic events 270, 0.4% 3, 0.91% 34, 0.3% 3, 0.19% 93, 0.55%  276, 0.60%
Death 105, 0.16% 3, 0.92% 11, 0.09% 9, 0.54% 42, 0.25% 82, 0.18%
Wound disruption 410, 0.61% 3, 1.05% 80, 0.71% 31, 1.84% 161, 0.95%  389, 0.84%
Neurological injury 124, 0.19% 0, 0% 38, 0.34% 10, 0.57% 42, 0.25% 92, 0.20%
Hardware failure 608, 0.91% 4, 1.26% 113, 1% 11, 0.63% 193, 1.14% 471, 1.01%
Hematoma formation 233, 0.35% 3, 0.99% 43, 0.38% 6, 0.33% 63, 0.37%  217, 0.47%
Length of Stay, Cost, and Readmissions Control Alcohol Use Tobacco/Nicotine Use Malnutrition Dyslipidemia Primary Hypertension
Average length of stay (days) ± SD 3.84 + 4.20 6.53 + 8.32 3.54 + 4.41 9.07 + 13.29 4.32 + 4.53 4.04 + 4.15
Average cost of index admission (USD) + SD $36,649 + $26,351 $45,279 + $39,727 $32,488 + $21,071 $59,936 + $57,341 $35,556 + $24,047 $34,353 + $23,587
Mean 30-day readmission rate, n (%) 6,709, 4.84% 39, 5.94% 1,057, 5.14% 210, 6.57% 2,076, 6.26% 5,162, 6.07%
Mean 90-day readmission rate, n (%) 8,067, 8.01% 63, 12.70% 1,532, 9.24% 329, 12.87% 2,768, 10.78% 7,102, 10.26%
Mean 180-day readmission rate, n (%) 7,375, 11.01% 56, 18.06% 1,495, 13.22% 312, 18.47% 2,609, 15.37% 6,732, 14.50%